Results
|
1.
|
Low-temperature electrocautery reduces adverse effects from secondary cardiac implantable electronic device procedures: Insights from the WRAP-IT trial. MedStar authors:
Year: 2021
Citation: - Heart Rhythm. 18(7):1142-1150, 2021 07.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Berman BJ, Eldadah Z, Holbrook R, Kennergren C, Lande JD, Lexcen DR, Love JC, Martinez-Arraras J, Mittal S, Moubarak JB, Philippon F, Pickett RA, Poole JE, Riggio D, Schaller RD, Sholevar DP, Tarakji KG, Wilkoff BL, Wright DJ
|
|
2.
|
Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator: Primary Results of a Randomized Study. MedStar authors:
Citation: - Journal of the American College of Cardiology. 65(24):2581-8, 2015 Jun 23.
Institution: - MedStar Washington Hospital Center
All authors: - Al Fagih A, Albert T, Cerkvenik J, Ciuffo A, Evera MRI Study Investigators, Gold MR, Kanal E, Landborg L, Lee S, Merkely B, Peterson M, Schwitter J, Sommer T
|
|
3.
|
Design and rationale of the ANALYZE ST study: a prospective, nonrandomized, multicenter ST monitoring study to detect acute coronary syndrome events in implantable cardioverter-defibrillator patients. MedStar authors:
Year: 2014
Citation: - American Heart Journal. 168(4):424-429.e1, 2014 Oct.
Institution: - MedStar Heart & Vascular Institute
All authors: - Gibson CM, Holmes D, Kirtane AJ, Krucoff M, Mackall JA, Matthews R, Rao SV, Saba S, Waksman R
|
|
4.
|
Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD). MedStar authors:
Citation: - Heart Rhythm. 11(8):1377-83, 2014 Aug.
Institution: - MedStar Heart & Vascular Institute
All authors: - Blasco-Colmenares E, Butcher B, Cheng A, Dickfeld T, Eldadah Z, Ellenbogen KA, Guallar E, Kennedy R, Marine JE, Norgard S, Tomaselli GF, Zhang Y
|
|
5.
|
|